SYBLEU Inc
$0.06+0.00%(+$0.00)
TickerSpark Score
49/100
60
Valuation
60
Profitability
55
Growth
40
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SYBE research report →
52-Week Range100% of range
Low $0.04
Current $0.06
High $0.06
Companywww.sybleu.com
SYBLEU INC. intends to engage primarily in the development of regenerative medical applications. The company was founded in 2020 and is based in Bronx, New York.
- CEO
- Joseph G. Vaini
- IPO
- 2023
- Employees
- 2
- HQ
- Bronx, NY, US
Price Chart
+0.00% · this period
Valuation
- Market Cap
- $583.74K
- P/E
- -3.15
- P/S
- 49.91
- P/B
- -2.14
- EV/EBITDA
- -4.85
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 100.00%
- Op Margin
- -1275.48%
- Net Margin
- -1541.59%
- ROE
- 69.88%
- ROIC
- -501.99%
Growth & Income
- Revenue
- $11.70K · -0.03%
- Net Income
- $-180,304 · 26.51%
- EPS
- $-0.02 · 24.24%
- Op Income
- $-149,180
- FCF YoY
- -28.06%
Performance & Tape
- 52W High
- $0.06
- 52W Low
- $0.04
- 50D MA
- $0.06
- 200D MA
- $0.06
- Beta
- 1.74
- Avg Volume
- 2.43K
Get TickerSpark's AI analysis on SYBE
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SYBE Coverage
We haven't published any research on SYBE yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SYBE Report →